Diffuse large B-cell lymphoma trials in Norway
2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 2Not yet recruitingResearch participation
HOVON 168:Study on epcoritamab in frail patients with diffuse large B-Cell lymphoma (DLBCL) who have not been treated before
- Where
- DO NOT EDIT
- Age
- 65 years and over
- People
- 276 worldwide
- Run by
- Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
See details and how to join2025-524230-25-00EU 2025-524230-25-00Registry updated 2026-10-27
Phase 3RecruitingTrial-stage medicine
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
- Where
- Bergen, Gjoevik, Graalum, Loerenskog, Oslo, Stavanger, Tonsberg, Trondheim
- Age
- 75 years and over
- People
- 300 worldwide
- Run by
- Nordic Lymphoma Group
See details and how to joinNCT04332822EU 2022-502887-19-00Registry updated 2024-09-19
All Diffuse large B-cell lymphoma trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.